Literature DB >> 28455646

Controlling Hypertension: We Have the Tools-We Just Need to Use Them.

David J Hyman1, Valory Pavlik2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28455646      PMCID： PMC5515793          DOI： 10.1007/s11606-017-4060-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  13 in total

1.  Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.

Authors:  Michele R Hanselin; Joseph J Saseen; Richard R Allen; Joel C Marrs; Kavita V Nair
Journal:  Hypertension       Date:  2011-10-31       Impact factor: 10.190

2.  Darusentan in resistant hypertension: lost in translation.

Authors:  Frank Enseleit; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

3.  Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial.

Authors:  Melvin D Lobo; Paul A Sobotka; Alice Stanton; John R Cockcroft; Neil Sulke; Eamon Dolan; Markus van der Giet; Joachim Hoyer; Stephen S Furniss; John P Foran; Adam Witkowski; Andrzej Januszewicz; Danny Schoors; Konstantinos Tsioufis; Benno J Rensing; Benjamin Scott; G André Ng; Christian Ott; Roland E Schmieder
Journal:  Lancet       Date:  2015-01-23       Impact factor: 79.321

Review 4.  Renal denervation for resistant hypertension.

Authors:  Giuseppe Coppolino; Anna Pisano; Laura Rivoli; Davide Bolignano
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

5.  Management of Resistant Hypertension: Do Not Give Up on Medication.

Authors:  Eric Judd; David A Calhoun
Journal:  Nephrol Self Assess Program       Date:  2014-03

Review 6.  Medication adherence and resistant hypertension.

Authors:  D J Hyman; V Pavlik
Journal:  J Hum Hypertens       Date:  2014-09-11       Impact factor: 3.012

Review 7.  Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses.

Authors:  George C Roush; Michael E Ernst; John B Kostis; Shamima Yeasmin; Domenic A Sica
Journal:  J Hypertens       Date:  2016-01       Impact factor: 4.844

Review 8.  Comparative effectiveness of fourth-line anti-hypertensive agents in resistant hypertension: A systematic review and meta-analysis.

Authors:  Sarah-Jo Sinnott; Laurie A Tomlinson; Adrian A Root; Rohini Mathur; Kathryn E Mansfield; Liam Smeeth; Ian J Douglas
Journal:  Eur J Prev Cardiol       Date:  2016-11-19       Impact factor: 7.804

9.  Understanding uncontrolled hypertension: is it the patient or the provider?

Authors:  Adam J Rose; Dan R Berlowitz; Michelle B Orner; Nancy R Kressin
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

Review 10.  Device-based Therapy for Hypertension.

Authors:  Fu L Ng; Manish Saxena; Felix Mahfoud; Atul Pathak; Melvin D Lobo
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.